Required Research Activities to Overcome Addiction Problems in Japan

10.4103/TPSY.TPSY_3_21

Kazutaka Ikeda；Soichiro Ide；Hiromi Takahashi-Omoe；Masabumi Minami；Hisatsugu Miyata；Mitsuo Kawato；Hitoshi Okamoto；Tetsuro Kikuchi；Yumiko Saito；Tomoaki Shirao；Yuko Sekino；Toshiya Murai；Toshihiko Matsumoto；Masako Iseki；Yoko Nishitani；Masahiko Sumitani；Hidehiko Takahashi；Shigeto Yamawaki；Tadashi Isa；Yoko Kamio

behavioral addiction ； drug dependence ； information sharing ； personalized medicine

台灣精神醫學

35卷1期（2021 / 03 / 01）

6 - 11

英文

Background: The term ＂addiction＂ encompasses both substance dependence and behavioral addiction and is associated with major societal problems. Measures to combat addiction are currently insufficient in Japan, and further research on addiction is necessary. Methods: Science Council of Japan (SCJ) has three subcommittees - the Addiction Subcommittee, Brain and Mind Subcommittee, and Neuroscience Subcommittee among others. Those three subcommittees are dealing directly or indirectly with addiction problems in Japan. Thus, all authors of this review, members of those subcommittees, collectively recommended what research activities are required in Japan for continuing effort in overcoming addiction problems in Japan. Results: We proposed the following measures. Proposal 1: Understand diversity in addiction and promote related research and education; Proposal 2: Promote personalized measures for patients with addiction disorders; Proposal 3: Foster addiction research personnel; Proposal 4: Develop new guidelines for the rehabilitation of patients with drug dependence; Proposal 5: Establish an institute specializing in addiction research and comprehensively handling information collection, research, countermeasures, treatment, and public relation related to addiction. Conclusion: The opinions of the review are based on the recommendations that were published in 2020 in Japanese by the Addiction Subcommittee, Brain and Mind Subcommittee, and Neuroscience Subcommittee of the SCJ. The authors here are sharing colleagues of Taiwanese Society of Psychiatry with these proposed research activities required to overcome addiction problems in Japan.

1. American Psychiatric Association(2013).Diagnostic and Statistical Manual of Mental Disorders.Washington, DC:American Psychiatric Association.
2. Cao, J,Hudziak, JJ,Li, D(2013).Multi-cultural association of the serotonin transporter gene (SLC6A4) with substance use disorder.Neuropsychopharmacology,38,1731-1747.
3. Chen, D,Liu, F,Yang, C(2012).Association between the TPH1 A218C polymorphism and risk of mood disorders and alcohol dependence: evidence from the current studies.J Affect Disord,138,27-33.
4. Clarke, TK,Bloch, PJ,Ambrose-Lanci, LM(2013).Further evidence for association of polymorphisms in the CNR1 gene with cocaine addiction: confirmation in an independent sample and meta-analysis.Addict Biol,18,702-708.
5. Crist, RC,Ambrose-Lanci, LM,Vaswani, M(2013).Case-control association analysis of polymorphisms in the δ-opioid receptor, OPRD1, with cocaine and opioid addicted populations.Drug Alcohol Depend,127,122-128.
6. Haerian, BS(2013).BDNF rs6265 polymorphism and drug addiction: a systematic review and meta-analysis.Pharmacogenomics,14,2055-2065.
7. Kebir, O,Gorsane, MA,Blecha, L(2011).Association of inflammation genes with alcohol dependence/abuse: a systematic review and a metaanalysis.Eur Addict Res,17,146-153.
8. Li, D,Gelernter, J(2012).Strong protective effect of the aldehyde dehydrogenase gene (ALDH2) 504lys (*2) allele against alcoholism and alcohol-induced medical diseases in Asians.Hum Genet,131,725-37.
9. Li, D,Zhao, H,Gelernter, J(2011).Strong association of the alcohol dehydrogenase 1B gene (ADH1B) with alcohol dependence and alcohol-induced medical diseases.Biol Psychiatry,70,504-512.
10. Li, D,Zhao, H,Gelernter, J(2012).Further clarification of the contribution of the ADH1C gene to vulnerability of alcoholism and selected liver diseases.Hum Genet,131,1361-1374.
11. Ma, Y,Wang, M,Yuan, W(2015).The significant association of Taq1A genotypes in DRD2/ANKK1 with smoking cessation in a large-scale meta-analysis of Caucasian populations.Transl Psychiatry,5,e686.
12. Matsushita, S(ed.)(2017).Interim Report of the National Survey Results in Health, Labor and Welfare Grants-in-Aid for Scientific Research: Epidemiological Survey, Biological Evaluation, and Studies on the Medical Care, Welfare, and Social Support on Gambling Disorders.Tokyo:Health, Labour and Welfare.
13. McHugh, RK,Hofmann, SG,Asnaani, A(2010).The serotonin transporter gene and risk for alcohol dependence: a meta-analytic review.Drug Alcohol Depend,108,1-6.
14. Ministry of Health, Labour and Welfare(2014).Labour and Welfare: Lifetime Experience Rate of Drug Use in Major Countries.Tokyo:Ministry of Health, Labour and Welfare.
15. Miyaoka, H(ed)(2015).Research Report of Health, Labour and Welfare Grants-in-Aid for Scientific Research: Studies on Current States of a Variety of Addiction and Development and Promotion of Recovery Program for Addiction.Tokyo:Ministry of Health, Labour and Welfare.
16. Miyata, H(ed.),Takada, K(ed.),Ikeda, K(ed.)(2019).Ikeda K: Molecular biological basics of drug sensitivity Addiction Science.Tokyo:Asakura Publishing.
17. Munafò, M,Clark, T,Johnstone, E(2004).The genetic basis for smoking behavior: a systematic review and meta-analysis.Nicotine Tob Res,6,583-597.
18. Munafò, MR,Matheson, IJ(2007).Association of the DRD2 gene Taq1A polymorphism and alcoholism: a meta-analysis of case-control studies and evidence of publication bias.Mol Psychiatry,12,454-461.
19. Olfson, E,Saccone, NL,Johnson, EO(2016).Rare, low frequency and common coding variants in CHRNA5 and their contribution to nicotine dependence in European and African Americans.Mol Psychiatry,21,601-607.
20. Stapleton, JA,Sutherland, G,O’Gara, C(2007).Association between dopamine transporter genotypes and smoking cessation: a meta-analysis.Addict Biol,12,221-226.
21. United Nations Office on Drugs and Crime(2014).World Drug Report 2014.New York:United Nations.
22. World Health Organization(2018).International Statistical Classification of Diseases and Related Health Problems.Geneva:World Health Organization.